Register to Learn the Basics
Learn the basics on how recognize, diagnose, and treat Malignant Hyperthermia by attending at the “MH Let’s Save a Life” conference where patients sit side-by-side with healthcare professionals, students, and families learning about MH from experts affiliated with MHAUS on September 14, 2013 from 10 am - 4 pm at St. Peter’s Health Partners - St. Peter’s Hospital located in Albany, NY. The inherited muscle disorder Malignant Hyperthermia (MH) is most often triggered by certain anesthetic drugs leading to a life-threatening crisis that requires prompt, specific treatment. In rare cases, MH may also be triggered by heat and exercise. The conference is sponsored by Malignant Hyperthermia Association of the United States in conjunction with St. Peter's Heath Partners: St. Peter’s Hospital, Albany Memorial, Samaritan Hospital and St. Mary's Hospital.
What is Malignant Hyperthermia
Malignant hyperthermia (MH) is a potentially fatal, inherited disorder usually associated with the administration of certain general anesthetics and/or the drug succinylcholine. The disorder is due to an acceleration of metabolism in skeletal muscle. The signs of MH include muscle rigidity, rapid heart rate, high body temperature, muscle breakdown and increased acid content. Immediate treatment with the drug dantrolene usually reverses the signs of MH. The underlying defect is abnormally increased levels of cell calcium in the skeletal muscle.
There is mounting evidence that some patients will also develop MH with exercise and/or on exposure to hot environments. Without proper and prompt treatment with dantrolene sodium, mortality is extremely high. The best way to protect yourself, your family, your patients and facility, is to be prepared before it's too late.
Upon completion, participants will be able to:
1) Identify the signs and symptoms of an MH event.
2) Enforce quick treatment regimen for MH event.
3) Explain the response plan for an MH event to other medical staff.
4) State proper patient safety steps to take in preparation for an MH-Susceptible patient.
5) Discuss MH testing options with patients and assist them in seeking further information. There are education credits available.
About the Malignant Hyperthermia Association of the United States (MHAUS):
MHAUS was founded families who lost their children to MH or could not find information about MH. In 1981 they found each other - and a doctor performing MH testing – and agreed “to make current information about MH available to all who need it!”
MH is inherited genetic disorder found in an estimated 1 out of 2,000 people. MH is triggered by certain anesthesia and most often experienced in individuals undergoing routine surgery but in rare cases MH can happen without anesthesia. Symptoms include body temperature of up to 107 degrees, muscle rigidity, system-wide organ failure, and possible death.
Today MHAUS provides information and resources to medical and lay communities through conferences, educational materials,ID tags, 24-hour MH Hotline, MHAUS website, and with the help of chapter groups like the newly formed New York MH Chapter Group of MHAUS
The mission of MHAUS is to promote optimum care and scientific understanding of MH and related disorders. MH episodes can happen at any time. MHAUS can help you prepare before it’s too late.